This Million Position Signals Conviction in Biotech Stock
When a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
Stock indices move on earnings, policy changes, and macro data. This intro covers the core catalysts that drive daily swings.
23,761 articlesWhen a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
Investors often wrestle with where to place bets: a volatile crypto project or a disruptive nuclear-tech equity. This...
A surprising shift in mega-cap leadership had investors buzzing: SpaceX briefly topped Amazon in market value. This p...
Imagine starting 2026 with $10,000 in intel. By mid-2026, that stake could push past $30,000 as the stock rallied. Th...
If BoA's three conditions for rate hikes come true, Bitcoin could face renewed pressure from rising borrowing costs a...
A director sold 33,000 Clear Secure shares worth about $1.5 million, sparking questions about the stock's outlook. Th...
When a gold stock soars 200%, even savvy investors reconsider risk. This article breaks down why trimming a large pos...
asml stock popped today as investors chased AI-driven demand for semiconductor equipment. This guide breaks down what...
Investors weighed the promise of Milestone Pharmaceuticals against the realities of a high-stakes biotech market. Thi...
A hedge fund made a sizable Ultragenyx purchase as the stock slipped about 30% over the prior year. This article brea...
When a COO sells a hefty block of stock as the market rewards the company with an big run, investors should look beyo...
Robinhood stock soared from its spring lows, delivering a eye-catching rally. But a deeper look at revenue mix, regul...